PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1090024
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1090024
Global Myelodysplastic Syndrome Treatment Market Size study, by Treatment Type, by End-User and Regional Forecasts 2022-2028
Global Myelodysplastic Syndrome (MDS) Treatment Market is valued at approximately USD XXXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Myelodysplastic Syndrome (MDS) Treatment is a term used to describe a category of bone marrow disorders in which the bone marrow fails to create enough healthy blood cells. MDS is also known as "bone marrow failure condition". Ineffective hematopoiesis, as well as anomalies in proliferation, differentiation, and apoptosis, characterise these illnesses. The increased R&D spending on new drug development and increasing public awareness have led to the adoption of Myelodysplastic Syndrome (MDS) Treatment across the forecast period. For Instance: as per Cancer.Net in 2022, every year, about 10,000 people in the United States are diagnosed with MDS. MDS is rare in adults under the age of 50. People in their 70s are the most likely to develop it. The number of people diagnosed with MDS each year is projected to rise as the US population continues to age. As per Congressional Budget Office 2021, the pharmaceutical sector spent $83 billion on research and development in 2019. Inflation-adjusted, that sum is around ten times what the industry spent every year in the 1980s. Also, some initiatives by the government to provide targeted therapies and attractive reimbursement policies are likely to increase the market growth during the forecast period. However, adverse effects caused by the medicine may impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the Global Myelodysplastic Syndrome (MDS) Treatment market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to increased R&D spending on new drug development and increasing public awareness. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as initiatives by the government to provide targeted therapies and attractive reimbursement policies would create lucrative growth prospects for the Myelodysplastic Syndrome (MDS) Treatment market across Asia-Pacific region.
Major market players included in this report are:
AbbVie Inc.
Accord Healthcare
Bristol-Myers Squibb
Jazz Pharmaceuticals Inc
Novartis AG
Lupin Pharmaceuticals
Otsuka America Pharmaceutical Inc.
Onconova Therapeutics
Takeda Pharmaceutical Company Limited
Astex Pharmaceuticals, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment:
Chemotherapy,
Immune Treatments
Stem Cell Transplant
Other Treatment Types
By End-User:
Hospitals
Specialty Clinics
Other End-Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Myelodysplastic Syndrome (MDS) Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Myelodysplastic Syndrome (MDS) Treatment Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Myelodysplastic Syndrome (MDS) Treatment Market, by Treatment Type, 2020-2028 (USD Billion)
- 1.2.3. Myelodysplastic Syndrome (MDS) Treatment Market, by End-User, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Myelodysplastic Syndrome (MDS) Treatment Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Myelodysplastic Syndrome (MDS) Treatment Market Dynamics
- 3.1. Myelodysplastic Syndrome (MDS) Treatment Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Increased R&D spending on new drug development
- 3.1.1.2. Increasing public awareness
- 3.1.2. Market Challenges
- 3.1.2.1. Adverse effects caused by the medicine
- 3.1.3. Market Opportunities
- 3.1.3.1. Initiatives by the government to provide targeted therapies and attractive reimbursement policies
- 3.1.1. Market Drivers
Chapter 4. Global Myelodysplastic Syndrome (MDS) Treatment Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Myelodysplastic Syndrome (MDS) Treatment Market, by Treatment Type
- 6.1. Market Snapshot
- 6.2. Global Myelodysplastic Syndrome (MDS) Treatment Market by Treatment Type, Performance - Potential Analysis
- 6.3. Global Myelodysplastic Syndrome (MDS) Treatment Market Estimates & Forecasts by Treatment Type, 2018-2028 (USD Billion)
- 6.4. Myelodysplastic Syndrome (MDS) Treatment Market, Sub Segment Analysis
- 6.4.1. Chemotherapy
- 6.4.2. Immune Treatments
- 6.4.3. Stem Cell Transplant
- 6.4.4. Other Treatment Types
Chapter 7. Global Myelodysplastic Syndrome (MDS) Treatment Market, by End-User
- 7.1. Market Snapshot
- 7.2. Global Myelodysplastic Syndrome (MDS) Treatment Market by End-User, Performance - Potential Analysis
- 7.3. Global Myelodysplastic Syndrome (MDS) Treatment Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
- 7.4. Myelodysplastic Syndrome (MDS) Treatment Market, Sub Segment Analysis
- 7.4.1. Hospitals
- 7.4.2. Specialty Clinics
- 7.4.3. Other End-Users
Chapter 8. Global Myelodysplastic Syndrome (MDS) Treatment Market, Regional Analysis
- 8.1. Myelodysplastic Syndrome (MDS) Treatment Market, Regional Market Snapshot
- 8.2. North America Myelodysplastic Syndrome (MDS) Treatment Market
- 8.2.1. U.S. Myelodysplastic Syndrome (MDS) Treatment Market
- 8.2.1.1. Treatment Type breakdown estimates & forecasts, 2018-2028
- 8.2.1.2. End-User breakdown estimates & forecasts, 2018-2028
- 8.2.2. Canada Myelodysplastic Syndrome (MDS) Treatment Market
- 8.2.1. U.S. Myelodysplastic Syndrome (MDS) Treatment Market
- 8.3. Europe Myelodysplastic Syndrome (MDS) Treatment Market Snapshot
- 8.3.1. U.K. Myelodysplastic Syndrome (MDS) Treatment Market
- 8.3.2. Germany Myelodysplastic Syndrome (MDS) Treatment Market
- 8.3.3. France Myelodysplastic Syndrome (MDS) Treatment Market
- 8.3.4. Spain Myelodysplastic Syndrome (MDS) Treatment Market
- 8.3.5. Italy Myelodysplastic Syndrome (MDS) Treatment Market
- 8.3.6. Rest of Europe Myelodysplastic Syndrome (MDS) Treatment Market
- 8.4. Asia-Pacific Myelodysplastic Syndrome (MDS) Treatment Market Snapshot
- 8.4.1. China Myelodysplastic Syndrome (MDS) Treatment Market
- 8.4.2. India Myelodysplastic Syndrome (MDS) Treatment Market
- 8.4.3. Japan Myelodysplastic Syndrome (MDS) Treatment Market
- 8.4.4. Australia Myelodysplastic Syndrome (MDS) Treatment Market
- 8.4.5. South Korea Myelodysplastic Syndrome (MDS) Treatment Market
- 8.4.6. Rest of Asia Pacific Myelodysplastic Syndrome (MDS) Treatment Market
- 8.5. Latin America Myelodysplastic Syndrome (MDS) Treatment Market Snapshot
- 8.5.1. Brazil Myelodysplastic Syndrome (MDS) Treatment Market
- 8.5.2. Mexico Myelodysplastic Syndrome (MDS) Treatment Market
- 8.6. Rest of The World Myelodysplastic Syndrome (MDS) Treatment Market
Chapter 9. Competitive Intelligence
- 9.1. Top Market Strategies
- 9.2. Company Profiles
- 9.2.1. AbbVie Inc.
- 9.2.1.1. Key Information
- 9.2.1.2. Overview
- 9.2.1.3. Financial (Subject to Data Availability)
- 9.2.1.4. Product Summary
- 9.2.1.5. Recent Developments
- 9.2.2. Accord Healthcare
- 9.2.3. Bristol-Myers Squibb
- 9.2.4. Jazz Pharmaceuticals Inc
- 9.2.5. Novartis AG
- 9.2.6. Lupin Pharmaceuticals
- 9.2.7. Otsuka America Pharmaceutical Inc.
- 9.2.8. Onconova Therapeutics
- 9.2.9. Takeda Pharmaceutical Company Limited
- 9.2.10. Astex Pharmaceuticals, Inc.
- 9.2.1. AbbVie Inc.
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption
LIST OF TABLES
- TABLE 1. Global Myelodysplastic Syndrome (MDS) Treatment Market, report scope
- TABLE 2. Global Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by Region 2018-2028 (USD Billion)
- TABLE 3. Global Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by Treatment Type 2018-2028 (USD Billion)
- TABLE 4. Global Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by End-User 2018-2028 (USD Billion)
- TABLE 5. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 6. Global Myelodysplastic Syndrome (MDS) Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 7. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 8. Global Myelodysplastic Syndrome (MDS) Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 9. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 10. Global Myelodysplastic Syndrome (MDS) Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 11. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 12. Global Myelodysplastic Syndrome (MDS) Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 13. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 14. Global Myelodysplastic Syndrome (MDS) Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 15. U.S. Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 16. U.S. Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 17. U.S. Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 18. Canada Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 19. Canada Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 20. Canada Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 21. UK Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 22. UK Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 23. UK Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 24. Germany Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 25. Germany Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 26. Germany Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 27. RoE Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 28. RoE Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 29. RoE Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 30. China Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 31. China Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 32. China Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 33. India Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 34. India Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 35. India Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 36. Japan Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 37. Japan Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 38. Japan Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 39. RoAPAC Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 40. RoAPAC Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 41. RoAPAC Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 42. Brazil Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 43. Brazil Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 44. Brazil Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 45. Mexico Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 46. Mexico Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 47. Mexico Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 48. RoLA Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 49. RoLA Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 50. RoLA Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 51. Row Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts, 2018-2028 (USD Billion)
- TABLE 52. Row Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 53. Row Myelodysplastic Syndrome (MDS) Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)
- TABLE 54. List of secondary sources, used in the study of Global Myelodysplastic Syndrome (MDS) Treatment Market
- TABLE 55. List of primary sources, used in the study of Global Myelodysplastic Syndrome (MDS) Treatment Market
- TABLE 56. Years considered for the study
- TABLE 57. Exchange rates considered
LIST OF FIGURES
List of figures
- FIG 1. Global Myelodysplastic Syndrome (MDS) Treatment Market, research methodology
- FIG 2. Global Myelodysplastic Syndrome (MDS) Treatment Market, Market estimation techniques
- FIG 3. Global Market size estimates & forecast methods
- FIG 4. Global Myelodysplastic Syndrome (MDS) Treatment Market, key trends 2021
- FIG 5. Global Myelodysplastic Syndrome (MDS) Treatment Market, growth prospects 2022-2028
- FIG 6. Global Myelodysplastic Syndrome (MDS) Treatment Market, porters 5 force model
- FIG 7. Global Myelodysplastic Syndrome (MDS) Treatment Market, pest analysis
- FIG 8. Global Myelodysplastic Syndrome (MDS) Treatment Market, value chain analysis
- FIG 9. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, 2018 & 2028 (USD Billion)
- FIG 10. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, 2018 & 2028 (USD Billion)
- FIG 11. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, 2018 & 2028 (USD Billion)
- FIG 12. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, 2018 & 2028 (USD Billion)
- FIG 13. Global Myelodysplastic Syndrome (MDS) Treatment Market by segment, 2018 & 2028 (USD Billion)
- FIG 14. Global Myelodysplastic Syndrome (MDS) Treatment Market, regional snapshot 2018 & 2028
- FIG 15. North America Myelodysplastic Syndrome (MDS) Treatment Market 2018 & 2028 (USD Billion)
- FIG 16. Europe Myelodysplastic Syndrome (MDS) Treatment Market 2018 & 2028 (USD Billion)
- FIG 17. Asia Pacific Myelodysplastic Syndrome (MDS) Treatment Market 2018 & 2028 (USD Billion)
- FIG 18. Latin America Myelodysplastic Syndrome (MDS) Treatment Market 2018 & 2028 (USD Billion)
- FIG 19. Global Myelodysplastic Syndrome (MDS) Treatment Market, company Market share analysis (2021)
